Madbullrun,
You must have your eyes shut.
BFC performance is,
- Q1 FY22/23 is approx $10m above average of past 8 Qtrs. Can't be sustained.
- Q1 FY 22/23 result manufactured out of unsold past stocks and existing production/stock (hand to mouth on Mozz). Lactoferrin big sales at low margin. All done for Cap raise and AGM and NAB.
- Market Cap today is approx $27m. NAB debt is approx $45m subject to Q1 FY22/23 release to NAB.
- Q2 FY22/23 and full year looks to drift back into negative CASH because,
- Mozz sales at negative gross margin. WOW and McCains prices are ???
- Lactoferrin sales come back to monthly run rate at possibly $200-300kg gross margin.
- Lactoferrin margin does not offset Mozz losses.
- No big costs cuts announced - why??
Note - Regal has been a seller since May 22. Why step up NOW? Cheap - yes but ???
- Forums
- ASX - By Stock
- BFC
- Ann: Notice of 2022 Annual General Meeting and Proxy Form
Ann: Notice of 2022 Annual General Meeting and Proxy Form, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BFC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.991M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BFC (ASX) Chart |
Day chart unavailable